Evaluation of the immunoprotective effects of IF-2 GTPase and SSU05-1022 as a candidate for a Streptococcus suis subunit vaccine

Future Microbiol. 2021 Jul:16:721-729. doi: 10.2217/fmb-2020-0232. Epub 2021 Jul 5.

Abstract

Aim: This study aims to develop a subunit vaccine with high cross-protection for Streptococcus suis. Materials & methods: Four-week-old female BALB/c mice were first immunized with a single and mixed protein. Various indicators, such as antibody titers and various cytokine levels, were further analyzed. Results: The results showed that purified recombinant proteins IF-2 and 1022 had a good protective effect against lethal doses of S. suis serotype 2 and S. suis serotype 9. This study showed immunization with recombinant proteins. Conclusion: IF-2 and 1022 can enhance cross-protection against S. suis serotypes 2 and 9.

Keywords: Streptococcus suis; cross-protection; subunit vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Vaccines / immunology*
  • Cross Protection
  • Female
  • GTP Phosphohydrolases* / immunology
  • Mice
  • Mice, Inbred BALB C
  • Recombinant Proteins / genetics
  • Streptococcus suis*
  • Vaccines, Subunit* / immunology

Substances

  • Bacterial Vaccines
  • Recombinant Proteins
  • Vaccines, Subunit
  • GTP Phosphohydrolases